Matthew C. Riddle - Concepedia

Author

Matthew C. Riddle

Oregon Health & Science University ORCID

Also Known As

Debra L. Simmons, G Nestadt, Grimm, Richard H., Home, P, Home, Philip D., Hu, Frank B, Kawamori, R, M C Riddle, M Riddle, M. C. Riddle

316

Publications

26.3K

Citations

H-Index

142

Concepts

All Affiliations

Oregon Health & Science University McMaster University Hamilton Health Sciences Population Health Research Institute University of Toronto

About

Matthew C. Riddle is an author at Oregon Health & Science University specializing in medicine, diabetes, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	53	9.1K
2	Health Sciences	12	15	1K
3	Arts	1	1	13
4	Engineering	1	1	16
5	Natural Sciences	1	1	31

Matthew C. Riddle

127

Publications

23.8K

Citations

H-Index

Page 1

	Year	Citations
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, The Lancet Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseHealth PolicyCardiovascular Outcomes	2019	2.8K
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome Marc A. Pfeffer, Brian Claggett, Rafael Díaz, New England Journal of Medicine	2015	2.3K
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure Deepak L. Bhatt, Michael Szarek, Philippe Gabríel Steg, New England Journal of Medicine	2020	1.7K
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed, The Lancet Diabetes ManagementCardiovascular DiseaseDiabetesClinical TrialsType 2	2018	1.7K
The Treat-to-Target Trial Matthew C. Riddle, Julio Rosenstock, John Gerich Diabetes Care	2003	1.5K
Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea David M. Kendall, Matthew C. Riddle, Julio Rosenstock, Diabetes Care	2005	1.2K
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease Deepak L. Bhatt, Michael Szarek, Bertram Pitt, New England Journal of Medicine	2020	1.1K
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, The Lancet Metabolic SyndromeDiabetes ManagementUrologyChronic Kidney DiseaseDiabetes	2019	600
Causal thinking and complex system approaches in epidemiology Sandro Galea, Matthew C. Riddle, G. A Kaplan International Journal of Epidemiology Disease StatesComputational EpidemiologyCausal InferenceObesityMetabolic Syndrome	2009	422
Comparison of Basal Insulin Added to Oral Agents Versus Twice-Daily Premixed Insulin as Initial Insulin Therapy for Type 2 Diabetes H. U. Janka, G. Plewe, Matthew C. Riddle, Diabetes Care	2005	413

Page 1